© The Rockefeller University Press, 0022-1007/1999/5/1545/ $5.00
The Journal of Experimental Medicine, Volume 189, Number 10, May 17, 1999 1545-1554
Constant Mean Viral Copy Number per Infected Cell in Tissues Regardless of High, Low, or Undetectable Plasma HIV RNA
Richard D. Hockett*,
J. Michael Kilby
,
Cynthia A. Derdeyn*,
Michael S. Saag
,
Michael Sillers
,
Kathleen Squires
,
Scott Chiz*,
Martin A. Nowak¶,
George M. Shaw
,||, and
R. Pat Bucy*,
From the * Department of Pathology, the
Department of Medicine, the
Department of Surgery, and the || Howard Hughes Medical Institute, University of Alabama at Birmingham, Birmingham, Alabama 35233-7331; and the ¶ Institute for Advanced Study, Princeton, New Jersey 08540
Quantitative analysis of the relationship between virus expression and disease outcome has been critical for understanding HIV-1 pathogenesis. Yet the amount of viral RNA contained within an HIV-expressing cell and the relationship between the number of virus-producing cells and plasma virus load has not been established or reflected in models of viral dynamics. We report here a novel strategy for the coordinated analysis of virus expression in lymph node specimens. The results obtained for patients with a broad range of plasma viral loads before and after antiretroviral therapy reveal a constant mean viral (v)RNA copy number (3.6 log10 copies) per infected cell, regardless of plasma virus load or treatment status. In addition, there was a significant but nonlinear direct correlation between the frequency of vRNA+ lymph node cells and plasma vRNA. As predicted from this relationship, residual cells expressing this same mean copy number are detectable (frequency <2/106 cells) in tissues of treated patients who have plasma vRNA levels below the current detectable threshold (<50 copies/ml). These data suggest that fully replication-active cells are responsible for sustaining viremia after initiation of potent antiretroviral therapy and that plasma virus titers correlate, albeit in a nonlinear fashion, with the number of virus-expressing cells in lymphoid tissue.
Key Words: HIV-1 infection quantitative RT-PCR lymph node biopsy in situ hybridization HIV pathogenesis
Address correspondence to R. Pat Bucy, Rm. W287 Spain-Wallace Bldg., Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35233-7331. Phone: 205-934-6246; Fax: 205-975-7074; E-mail: Bucy{at}uab.edu
This work was partially supported by Chiron Corp. and the Adult AIDS Clinical Trials Group.
Abbreviations used: FDC, follicular dendritic cell; HAART, highly active antiretroviral therapy; ISH, in situ hybridization; LDA, limiting dilution analysis; QC-RT-PCR, quantitative, competitive RT-PCR; UTP, uridine 5'-triphosphate; vRNA, viral RNA.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Cole, S. R., Napravnik, S., Mugavero, M. J., Lau, B., Eron, J. J. Jr, Saag, M. S.
(2010). Copy-Years Viremia as a Measure of Cumulative Human Immunodeficiency Virus Viral Burden. Am J Epidemiol
171: 198-205
[Abstract]
[Full Text]
-
Petravic, J., Ribeiro, R. M., Casimiro, D. R., Mattapallil, J. J., Roederer, M., Shiver, J. W., Davenport, M. P.
(2008). Estimating the Impact of Vaccination on Acute Simian-Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections. J. Virol.
82: 11589-11598
[Abstract]
[Full Text]
-
Vijay, N. N. V., Vasantika, , Ajmani, R., Perelson, A. S., Dixit, N. M.
(2008). Recombination increases human immunodeficiency virus fitness, but not necessarily diversity. J. Gen. Virol.
89: 1467-1477
[Abstract]
[Full Text]
-
Chen, H. Y., Di Mascio, M., Perelson, A. S., Ho, D. D., Zhang, L.
(2007). Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques. Proc. Natl. Acad. Sci. USA
104: 19079-19084
[Abstract]
[Full Text]
-
Fraser, C., Hollingsworth, T. D., Chapman, R., de Wolf, F., Hanage, W. P.
(2007). From the Cover: Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis. Proc. Natl. Acad. Sci. USA
104: 17441-17446
[Abstract]
[Full Text]
-
Rodriguez, B., Sethi, A. K., Cheruvu, V. K., Mackay, W., Bosch, R. J., Kitahata, M., Boswell, S. L., Mathews, W. C., Bangsberg, D. R., Martin, J., Whalen, C. C., Sieg, S., Yadavalli, S., Deeks, S. G., Lederman, M. M.
(2006). Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.. JAMA
296: 1498-1506
[Abstract]
[Full Text]
-
Fraser, C.
(2005). HIV recombination: what is the impact on antiretroviral therapy?. J R Soc Interface
2: 489-503
[Abstract]
[Full Text]
-
Balabanian, K., Harriague, J., Decrion, C., Lagane, B., Shorte, S., Baleux, F., Virelizier, J.-L., Arenzana-Seisdedos, F., Chakrabarti, L. A.
(2004). CXCR4-Tropic HIV-1 Envelope Glycoprotein Functions as a Viral Chemokine in Unstimulated Primary CD4+ T Lymphocytes. J. Immunol.
173: 7150-7160
[Abstract]
[Full Text]
-
Fondere, J.-M., Petitjean, G., Huguet, M.-F., Salhi, S. L., Baillat, V., Macura-Biegum, A., Becquart, P., Reynes, J., Vendrell, J.-P.
(2004). Human Immunodeficiency Virus Type 1 (HIV-1) Antigen Secretion by Latently Infected Resting CD4+ T Lymphocytes from HIV-1-Infected Individuals. J. Virol.
78: 10536-10542
[Abstract]
[Full Text]
-
Di Mascio, M., Markowitz, M., Louie, M., Hurley, A., Hogan, C., Simon, V., Follmann, D., Ho, D. D., Perelson, A. S.
(2004). Dynamics of Intermittent Viremia during Highly Active Antiretroviral Therapy in Patients Who Initiate Therapy during Chronic versus Acute and Early Human Immunodeficiency Virus Type 1 Infection. J. Virol.
78: 10566-10573
[Abstract]
[Full Text]
-
Lassen, K. G., Bailey, J. R., Siliciano, R. F.
(2004). Analysis of Human Immunodeficiency Virus Type 1 Transcriptional Elongation in Resting CD4+ T Cells In Vivo. J. Virol.
78: 9105-9114
[Abstract]
[Full Text]
-
Persaud, D., Siberry, G. K., Ahonkhai, A., Kajdas, J., Monie, D., Hutton, N., Watson, D. C., Quinn, T. C., Ray, S. C., Siliciano, R. F.
(2004). Continued Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads. J. Virol.
78: 968-979
[Abstract]
[Full Text]
-
Di Mascio, M., Markowitz, M., Louie, M., Hogan, C., Hurley, A., Chung, C., Ho, D. D., Perelson, A. S.
(2003). Viral Blip Dynamics during Highly Active Antiretroviral Therapy. J. Virol.
77: 12165-12172
[Abstract]
[Full Text]
-
Saag, M.
(2003). Is It Time To Proactively Switch Successful Antiretroviral Therapy? Carefully Check Your SWATCH. ANN INTERN MED
139: 148-149
[Full Text]
-
Hermankova, M., Siliciano, J. D., Zhou, Y., Monie, D., Chadwick, K., Margolick, J. B., Quinn, T. C., Siliciano, R. F.
(2003). Analysis of Human Immunodeficiency Virus Type 1 Gene Expression in Latently Infected Resting CD4+ T Lymphocytes In Vivo. J. Virol.
77: 7383-7392
[Abstract]
[Full Text]
-
Sherman, M. P., de Noronha, C. M. C., Eckstein, L. A., Hataye, J., Mundt, P., Williams, S. A. F., Neidleman, J. A., Goldsmith, M. A., Greene, W. C.
(2003). Nuclear Export of Vpr Is Required for Efficient Replication of Human Immunodeficiency Virus Type 1 in Tissue Macrophages. J. Virol.
77: 7582-7589
[Abstract]
[Full Text]
-
Frenkel, L. M., Wang, Y., Learn, G. H., McKernan, J. L., Ellis, G. M., Mohan, K. M., Holte, S. E., De Vange, S. M., Pawluk, D. M., Melvin, A. J., Lewis, P. F., Heath, L. M., Beck, I. A., Mahalanabis, M., Naugler, W. E., Tobin, N. H., Mullins, J. I.
(2003). Multiple Viral Genetic Analyses Detect Low-Level Human Immunodeficiency Virus Type 1 Replication during Effective Highly Active Antiretroviral Therapy. J. Virol.
77: 5721-5730
[Abstract]
[Full Text]
-
Di Mascio, M., Dornadula, G., Zhang, H., Sullivan, J., Xu, Y., Kulkosky, J., Pomerantz, R. J., Perelson, A. S.
(2003). In a Subset of Subjects on Highly Active Antiretroviral Therapy, Human Immunodeficiency Virus Type 1 RNA in Plasma Decays from 50 to <5 Copies per Milliliter, with a Half-Life of 6 Months. J. Virol.
77: 2271-2275
[Abstract]
[Full Text]
-
Yeni, P. G., Hammer, S. M., Carpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schechter, M., Schooley, R. T., Thompson, M. A., Vella, S., Volberding, P. A.
(2002). Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel. JAMA
288: 222-235
[Abstract]
[Full Text]
-
Pierson, T. C., Kieffer, T. L., Ruff, C. T., Buck, C., Gange, S. J., Siliciano, R. F.
(2002). Intrinsic Stability of Episomal Circles Formed during Human Immunodeficiency Virus Type 1 Replication. J. Virol.
76: 4138-4144
[Abstract]
[Full Text]
-
Ortiz, G. M., Hu, J., Goldwitz, J. A., Chandwani, R., Larsson, M., Bhardwaj, N., Bonhoeffer, S., Ramratnam, B., Zhang, L., Markowitz, M. M., Nixon, D. F.
(2002). Residual Viral Replication during Antiretroviral Therapy Boosts Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses in Subjects Treated Early after Infection. J. Virol.
76: 411-415
[Abstract]
[Full Text]
-
Eckstein, D. A., Sherman, M. P., Penn, M. L., Chin, P. S., De Noronha, C. M.C., Greene, W. C., Goldsmith, M. A.
(2001). HIV-1 Vpr Enhances Viral Burden by Facilitating Infection of Tissue Macrophages but Not Nondividing CD4+ T Cells. JEM
194: 1407-1419
[Abstract]
[Full Text]
-
Hosmalin, A., Samri, A., Dumaurier, M.-J., Dudoit, Y., Oksenhendler, E., Karmochkine, M., Autran, B., Wain-Hobson, S., Cheynier, R.
(2001). HIV-specific effector cytotoxic T lymphocytes and HIV-producing cells colocalize in white pulps and germinal centers from infected patients. Blood
97: 2695-2701
[Abstract]
[Full Text]
-
Muller, V., Maree, A. F. M., De Boer, R. J.
(2001). Release of Virus from Lymphoid Tissue Affects Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Kinetics in the Blood. J. Virol.
75: 2597-2603
[Abstract]
[Full Text]
-
Engelmayer, J., Larsson, M., Lee, A., Lee, M., Cox, W. I., Steinman, R. M., Bhardwaj, N.
(2001). Mature Dendritic Cells Infected with Canarypox Virus Elicit Strong Anti-Human Immunodeficiency Virus CD8+ and CD4+ T-Cell Responses from Chronically Infected Individuals. J. Virol.
75: 2142-2153
[Abstract]
[Full Text]
-
Brodie, S. J.
(2000). Nonlymphoid reservoirs of HIV replication in children with chronic-progressive disease. J. Leukoc. Biol.
68: 351-359
[Abstract]
[Full Text]
-
Clementi, M.
(2000). Quantitative Molecular Analysis of Virus Expression and Replication. J. Clin. Microbiol.
38: 2030-2036
[Full Text]
-
Henry, K.
(2000). The Case for More Cautious, Patient-Focused Antiretroviral Therapy. ANN INTERN MED
132: 306-311
[Abstract]
[Full Text]
-
Carpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schechter, M., Schooley, R. T., Thompson, M. A., Vella, S., Yeni, P. G., Volberding, P. A.
(2000). Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society-USA Panel. JAMA
283: 381-390
[Abstract]
[Full Text]
-
Dornadula, G., Zhang, H., VanUitert, B., Stern, J., Livornese, L. Jr, Ingerman, M. J., Witek, J., Kedanis, R. J., Natkin, J., DeSimone, J., Pomerantz, R. J.
(1999). Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral Therapy. JAMA
282: 1627-1632
[Abstract]
[Full Text]
-
D'Aquila, R., Walker, B.
(1999). Exploring the Benefits and Limits of Highly Active Antiretroviral Therapy. JAMA
282: 1668-1669
[Full Text]
-
McCoig, C., Van Dyke, G., Chou, C.-S., Picker, L. J., Ramilo, O., Vitetta, E. S.
(1999). An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro. Proc. Natl. Acad. Sci. USA
96: 11482-11485
[Abstract]
[Full Text]
-
Fraser, C., Ferguson, N. M., Anderson, R. M.
(2001). Quantification of intrinsic residual viral replication in treated HIV-infected patients. Proc. Natl. Acad. Sci. USA
98: 15167-15172
[Abstract]
[Full Text]